|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Humanigen, Inc.
| | | Phone: | (650) 243-3100 | Fax: | (650) 243-3260 | Year Established: | 2001 | Employees: | 35 | Ticker: | HGEN | Exchange: | OTCQB | Main Contact: | Cameron Durrant, MD, MBA, Chairman & CEO | | Other Contacts: | Tarek Sahmoud, M.D., Ph.D., CMO Greg Jester, CFO Morgan Lam, CSO
| | Company Description | Humanigen, formerly KaloBios, is an emerging biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases through innovative and responsible business models. Lead compounds in the KaloBios portfolio are benznidazole for the potential treatment of Chagas disease in the U.S., and the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab (formerly KB004), for the potential treatment of various solid and hematologic cancers such as CMML and potentially JMML. | |
|
|
|
|
|